Our website uses cookies, which are small text files that are intended to make the site better for you to use, and that help us understand how people interact with our content so that we can make it better.

    You can find out more details about Clue's approach to privacy by reading our Privacy Policy

    These cookies are necessary for the website to function and cannot be switched off.

    They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. These cookies do not store any personally identifiable information.

    The Clue website uses third-party analysis and tracking services to track the performance of our services, understand how you use our services, and offer you an improved experience.

    You may withdraw your consent to this processing of your data at any time. One way to so is by generally disabling cookies on your device (which will also affect your other online activities). Or you can disable cookies specifically for this website by switching the toggle to 'Off'.

    You can read more about how Clue handles and thinks about data in the following blog posts written by our founder and CEO, Ida Tin.

    The journey of a single data pointThe journey of a single data point, Part II: The underworld of digital advertisingThe journey of a single data point, Part III: About the selling of health data

Your Privacy

Our website uses cookies, which are small text files that are intended to make the site better for you to use, and that help us understand how people interact with our content so that we can make it better.

You can find out more details about Clue's approach to privacy by reading our Privacy Policy

Your Privacy

We use cookies on our website to analyze how people use it and improve the experience.

You can read more about how we use cookies in our Privacy Policy, or manage your preferences here.

About Clue

Research partner profile: Dr. Alexandra Alvergne at Oxford

  • Share this article on Twitter
  • Share this article on Facebook
  • Share this article with WhatsApp

Name: Dr. Alexandra Alvergne[2]

Location: University of Oxford, United Kingdom

Profession: Associate Professor in Biocultural Anthropology

Degree: PhD in Human Evolutionary Biology and Ecology

About: Dr. Alexandra Alvergne is on a mission to help people better understand their bodies.

Alex wants to shift from a general medicalization of female health to a more holistic, ecological and evolutionary perspective. So what exactly does that mean? Currently, the medical and health industries are treating symptoms rather than considering the root of various medical conditions and problems.

Dr. Alvergne wants to take a broader look at treatment, and thinks we need to shift from a rigid "normal" vs. "pathological" perspective to a fluid ecological approach that takes into consideration diversity and change.

An ecological perspective on care and prevention would look at social, cultural, economic, political, nutritional, (epi)genetic and microbial factors. It would also avoid looking at female health through a lens that only focuses on reproductive function.

Goal: Dr. Alvergne wants to see what we can learn by researching the natural evolution and variation in menstrual cycles. Every person and cycle is different, and we can learn a lot from variation rather than automatically prescribing a pill or a fix.

She would also like to help people discover they have a sexually transmitted infection sooner, so they can get treatment as soon as possible.

How: Dr. Alvergne thinks that academia and research can move faster by partnering with businesses and focusing on user-led research.

Although Alex would like to move away from a medicalization of female health, she acknowledges that we need pharmaceutical companies. It's easy to point fingers at big pharma because in reality, they have strong economic interests. However, if they don't make money, they won't survive. Simple as that. The question is how we can direct pharmaceutical companies in a more inclusive and open direction that covers aspects of diversity. Alex thinks they could benefit from building links with nonprofits and taking a deeper look into medical anthropology.

Current research: Human ecology and fertility, contraception adoption & discontinuation, vaccination decision making

Past research: Hormonal birth control and mate choice, contraceptive uptake

Connect with Dr. Alvergne and get updates on her research. Follow her on Twitter.[3]

You might also like to read

Popular Articles